Study to Evaluate Efficacy and Safety of Benralizumab in Reducing Oral Corticosteroid Use in Adult Patients With Severe Asthma

NCT03557307 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

598

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

BIOLOGICAL: Benralizumab

Sponsor

AstraZeneca